Skip to main content
SpringerLink
Log in

PCSK9-Inhibitor induziert Rückbildung koronarer Plaques

  • Medizin aktuell
  • Published:
CardioVasc Aims and scope

Die erste Studie mit einem PCSK9-Hemmer und IVUS-Bildgebung zeigt, dass bei zwei Drittel aller KHK-Patienten eine Rückbildung von Koronarplaques erreicht werden kann, wenn sie Statine plus Evolocumab einnehmen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Quelle

  • Nicholls SJ et al. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients. The GLAGOV Randomized Clinical Trial. AHA-Kongress, 12.–16.11.2016 in New Orleans

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Dirk Einecke

Authors
  1. Dirk Einecke
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Einecke, D. PCSK9-Inhibitor induziert Rückbildung koronarer Plaques. CV 16, 13–14 (2016). https://doi.org/10.1007/s15027-016-1016-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15027-016-1016-6

Search

Navigation